Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Meister

Showing results (61-70 of 81) with videos related to

Pageof 9
Sort By:
Kidney International|November 4, 2022
SARS-CoV-2 vaccination improves HBV seroconversion rate through heterological immunityMoritz Anft, Krystallenia Paniskaki, Tina Giglio, et al.
The American Journal of Pathology|August 1, 2012
Virulence factors identified by Cryptococcus neoformans mutant screen differentially modulate lung immune responses and brain disseminationXiumiao He, Daniel M Lyons, Dena L Toffaletti, et al.
Kidney International|September 12, 2021
A third vaccine dose substantially improves humoral and cellular SARS-CoV-2 immunity in renal transplant recipients with primary humoral nonresponseTimm H Westhoff, Felix S Seibert, Moritz Anft, et al.
Frontiers in Immunology|November 17, 2022
Superior humoral immunity in vaccinated SARS-CoV-2 convalescence as compared to SARS-COV-2 infection or vaccinationKrystallenia Paniskaki, Margarethe J Konik, Moritz Anft, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 13, 2023
Humoral and cellular immune responses to repeated SARS-CoV-2 infection and vaccination in an individual living with HIVAgit Simsek, Clara Bessen, Toni L Meister, et al.
Kidney International Reports|February 7, 2022
A Vector-Based Vaccine Dose After 3 Doses of mRNA-Based COVID-19 Vaccination Does Not Substantially Improve Humoral SARS-CoV-2 Immunity in Renal Transplant RecipientsToralf Roch, Benjamin Rohn, Arturo Blazquez-Navarro, et al.
Frontiers in Microbiology|June 19, 2023
Low avidity circulating SARS-CoV-2 reactive CD8+ T cells with proinflammatory TEMRA phenotype are associated with post-acute sequelae of COVID-19Krystallenia Paniskaki, Margarethe J Konik, Moritz Anft, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|December 26, 2023
Increased SARS-CoV-2 reactive low avidity T cells producing inflammatory cytokines in pediatric post-acute COVID-19 sequelae (PASC)Krystallenia Paniskaki, Sarah Goretzki, Moritz Anft, et al.
Hepatology (Baltimore, Md.)|February 6, 2023
EGF receptor modulates HEV entry in human hepatocytesJil A Schrader, Thomas L Burkard, Yannick Brüggemann, et al.
BMC Infectious Diseases|November 22, 2023
Fading SARS-CoV-2 humoral VOC cross-reactivity and sustained cellular immunity in convalescent children and adolescentsKrystallenia Paniskaki, Sarah Goretzki, Moritz Anft, et al.
Pageof 9

Showing results (61-70 of 81) with videos related to

Sort By:
Pageof 9
Kidney International|November 4, 2022
SARS-CoV-2 vaccination improves HBV seroconversion rate through heterological immunityMoritz Anft, Krystallenia Paniskaki, Tina Giglio, et al.
The American Journal of Pathology|August 1, 2012
Virulence factors identified by Cryptococcus neoformans mutant screen differentially modulate lung immune responses and brain disseminationXiumiao He, Daniel M Lyons, Dena L Toffaletti, et al.
Kidney International|September 12, 2021
A third vaccine dose substantially improves humoral and cellular SARS-CoV-2 immunity in renal transplant recipients with primary humoral nonresponseTimm H Westhoff, Felix S Seibert, Moritz Anft, et al.
Frontiers in Immunology|November 17, 2022
Superior humoral immunity in vaccinated SARS-CoV-2 convalescence as compared to SARS-COV-2 infection or vaccinationKrystallenia Paniskaki, Margarethe J Konik, Moritz Anft, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 13, 2023
Humoral and cellular immune responses to repeated SARS-CoV-2 infection and vaccination in an individual living with HIVAgit Simsek, Clara Bessen, Toni L Meister, et al.
Kidney International Reports|February 7, 2022
A Vector-Based Vaccine Dose After 3 Doses of mRNA-Based COVID-19 Vaccination Does Not Substantially Improve Humoral SARS-CoV-2 Immunity in Renal Transplant RecipientsToralf Roch, Benjamin Rohn, Arturo Blazquez-Navarro, et al.
Frontiers in Microbiology|June 19, 2023
Low avidity circulating SARS-CoV-2 reactive CD8+ T cells with proinflammatory TEMRA phenotype are associated with post-acute sequelae of COVID-19Krystallenia Paniskaki, Margarethe J Konik, Moritz Anft, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|December 26, 2023
Increased SARS-CoV-2 reactive low avidity T cells producing inflammatory cytokines in pediatric post-acute COVID-19 sequelae (PASC)Krystallenia Paniskaki, Sarah Goretzki, Moritz Anft, et al.
Hepatology (Baltimore, Md.)|February 6, 2023
EGF receptor modulates HEV entry in human hepatocytesJil A Schrader, Thomas L Burkard, Yannick Brüggemann, et al.
BMC Infectious Diseases|November 22, 2023
Fading SARS-CoV-2 humoral VOC cross-reactivity and sustained cellular immunity in convalescent children and adolescentsKrystallenia Paniskaki, Sarah Goretzki, Moritz Anft, et al.
Pageof 9